Literature DB >> 20971132

Very small embryonic-like stem cells in cardiovascular repair.

Wojciech Wojakowski1, Magda Kucia, Ewa Zuba-Surma, Tomasz Jadczyk, Beata Książek, Mariusz Z Ratajczak, Michał Tendera.   

Abstract

Adult bone marrow (BM) harbors several small populations of cells which may contribute to cardiac and endothelial repair, such as endothelial progenitor cells (EPCs), mesenchymal stromal cells (MSCs) and very small embryonic-like cells (VSELs) expressing several markers of pluripotent stem cells (PSCs), such as Oct-4, Nanog and SSEA-1. Such cells were identified in mice bone marrow, peripheral blood and solid organs as well as in umbilical cord blood (UCB) and peripheral blood (PB) in humans. The adult BM-derived VSELs may undergo differentiation into cells derived for all three germ layers, including cardiomyocytes and vascular endothelial cells. VSELs can be isolated using a multiparameter live cell sorting technique with special gating strategy based on their small size, expression of stem cell markers (Sca-1 in mice, CXCR4 and CD133 in humans) and absence of hematopoietic lineage markers (CD45(-) Lin(-)). Experiments in murine models of myocardial infarction (MI) demonstrated population of VSELs expressed also early markers of cardiac and endothelial lineages (GATA-4, Nkx2.5/Csx, VE-cadherin, von Willebrand factor) which migrated to stromal-derived factor-1 (SDF-1) and other chemoattractant gradient and underwent rapid mobilization into peripheral blood in experimental MI mice models. Recently, we demonstrated the mobilization of VSELs expressing PSC, early cardiac and endothelial markers in patients with acute MI. In addition to BM, VSELs were also identified in several murine solid organs including the heart and brain, as well as in umbilical cord blood and peripheral blood in adult humans. We hypothesized that VSELs are quiescent progeny of epiblast-derived PSCs that are deposited during organogenesis in developing organs. In experimental MI intramyocardial injection of VSELs was more efficient than that of HSCs at improving left ventricular ejection fraction and attenuation of myocardial hypertrophy. VSELs can be useful in translational studies of cardiovascular repair.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20971132      PMCID: PMC3005032          DOI: 10.1016/j.pharmthera.2010.09.012

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  34 in total

1.  Mobilization of CD34(+), CD117(+), CXCR4(+), c-met(+) stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction.

Authors:  Wojciech Wojakowski; Michal Tendera; Anna Zebzda; Anna Michalowska; Marcin Majka; Magdalena Kucia; Katarzyna Maslankiewicz; Rafal Wyderka; Marek Król; Andrzej Ochala; Krystyna Kozakiewicz; Mariusz Z Ratajczak
Journal:  Eur Heart J       Date:  2005-11-02       Impact factor: 29.983

Review 2.  Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells.

Authors:  M Kucia; R Reca; V R Jala; B Dawn; J Ratajczak; M Z Ratajczak
Journal:  Leukemia       Date:  2005-07       Impact factor: 11.528

3.  The migration of bone marrow-derived non-hematopoietic tissue-committed stem cells is regulated in an SDF-1-, HGF-, and LIF-dependent manner.

Authors:  Magda Kucia; Wojtek Wojakowski; Ryan Reca; Bogdan Machalinski; Jolanta Gozdzik; Marcin Majka; Jarek Baran; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2006-03-28       Impact factor: 4.291

Review 4.  Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.

Authors:  Magda Kucia; Ryan Reca; Katarzyna Miekus; Jens Wanzeck; Wojtek Wojakowski; Anna Janowska-Wieczorek; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  Stem Cells       Date:  2005-05-11       Impact factor: 6.277

5.  Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction.

Authors:  Wojciech Wojakowski; Michał Tendera; Anna Michałowska; Marcin Majka; Magdalena Kucia; Katarzyna Maślankiewicz; Rafał Wyderka; Andrzej Ochała; Mariusz Z Ratajczak
Journal:  Circulation       Date:  2004-11-08       Impact factor: 29.690

6.  Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction.

Authors:  Magda Kucia; Buddhadeb Dawn; Greg Hunt; Yiru Guo; Marcin Wysoczynski; Marcin Majka; Janina Ratajczak; Francine Rezzoug; Suzanne T Ildstad; Roberto Bolli; Mariusz Z Ratajczak
Journal:  Circ Res       Date:  2004-11-18       Impact factor: 17.367

Review 7.  Mesenchymal stem cells and their potential as cardiac therapeutics.

Authors:  Mark F Pittenger; Bradley J Martin
Journal:  Circ Res       Date:  2004-07-09       Impact factor: 17.367

8.  Isolation and expansion of adult cardiac stem cells from human and murine heart.

Authors:  Elisa Messina; Luciana De Angelis; Giacomo Frati; Stefania Morrone; Stefano Chimenti; Fabio Fiordaliso; Monica Salio; Massimo Battaglia; Michael V G Latronico; Marcello Coletta; Elisabetta Vivarelli; Luigi Frati; Giulio Cossu; Alessandro Giacomello
Journal:  Circ Res       Date:  2004-10-07       Impact factor: 17.367

9.  Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction.

Authors:  Margherita Massa; Vittorio Rosti; Maurizio Ferrario; Rita Campanelli; Isabella Ramajoli; Roberta Rosso; Gaetano M De Ferrari; Marco Ferlini; Lucio Goffredo; Alessandra Bertoletti; Catherine Klersy; Alessandro Pecci; Remigio Moratti; Luigi Tavazzi
Journal:  Blood       Date:  2004-09-02       Impact factor: 22.113

10.  A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow.

Authors:  M Kucia; R Reca; F R Campbell; E Zuba-Surma; M Majka; J Ratajczak; M Z Ratajczak
Journal:  Leukemia       Date:  2006-05       Impact factor: 11.528

View more
  13 in total

Review 1.  Peripheral blood stem cells: phenotypic diversity and potential clinical applications.

Authors:  Yichi Zhang; Bing Huang
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 2.  Potential applications of germline cell-derived pluripotent stem cells in organ regeneration.

Authors:  Sharmila Fagoonee; Rinaldo Pellicano; Lorenzo Silengo; Fiorella Altruda
Journal:  Organogenesis       Date:  2011-04-01       Impact factor: 2.500

3.  Mesenchymal stem cells in post-surgical cavities of large maxillary bone lesions.

Authors:  Roberto Bertolai; Carlo Catelani; Mattia Signorini; Alessandro Rossi; Domenico Giannini
Journal:  Clin Cases Miner Bone Metab       Date:  2017-02-10

Review 4.  Stem Cell Sources and Graft Material for Vascular Tissue Engineering.

Authors:  Dorothee Hielscher; Constanze Kaebisch; Benedikt Julius Valentin Braun; Kevin Gray; Edda Tobiasch
Journal:  Stem Cell Rev Rep       Date:  2018-10       Impact factor: 5.739

5.  Psychopathology and Stem Cell Mobilization in Ultra-High Risk of Psychosis and First-Episode Psychosis Patients.

Authors:  Katarzyna Waszczuk; Jolanta Kucharska-Mazur; Ernest Tyburski; Katarzyna Rek-Owodziń; Piotr Plichta; Krzysztof Rudkowski; Piotr Podwalski; Tomasz Grąźlewski; Monika Mak; Błażej Misiak; Anna Michalczyk; Maciej Tarnowski; Katarzyna Sielatycka; Angelika Szczęśniak; Karolina Łuczkowska; Barbara Dołęgowska; Marta Budkowska; Mariusz Z Ratajczak; Jerzy Samochowiec
Journal:  Int J Environ Res Public Health       Date:  2022-05-15       Impact factor: 4.614

6.  Gelatin Based Polymer Cell Coating Improves Bone Marrow-Derived Cell Retention in the Heart after Myocardial Infarction.

Authors:  Anuhya Gottipati; Lakshman Chelvarajan; Hsuan Peng; Raymond Kong; Calvin F Cahall; Cong Li; Himi Tripathi; Ahmed Al-Darraji; Shaojing Ye; Eman Elsawalhy; Ahmed Abdel-Latif; Brad J Berron
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

7.  GSK3 inhibitor-BIO regulates proliferation of female germline stem cells from the postnatal mouse ovary.

Authors:  Y Hu; Y Bai; Z Chu; J Wang; L Wang; M Yu; Z Lian; J Hua
Journal:  Cell Prolif       Date:  2012-05-10       Impact factor: 6.831

Review 8.  Very small embryonic-like stem cells: implications in reproductive biology.

Authors:  Deepa Bhartiya; Sreepoorna Unni; Seema Parte; Sandhya Anand
Journal:  Biomed Res Int       Date:  2013-02-13       Impact factor: 3.411

9.  Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary.

Authors:  Chantel Samardzija; Michael Quinn; Jock K Findlay; Nuzhat Ahmed
Journal:  J Ovarian Res       Date:  2012-11-21       Impact factor: 4.234

10.  Identification of New Rat Bone Marrow-Derived Population of Very Small Stem Cell with Oct-4A and Nanog Expression by Flow Cytometric Platforms.

Authors:  Anna Labedz-Maslowska; Elzbieta Kamycka; Sylwia Bobis-Wozowicz; Zbigniew Madeja; Ewa K Zuba-Surma
Journal:  Stem Cells Int       Date:  2015-11-08       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.